David O. Walterhouse, MD

Section Head, Oncology; Attending physician, Hematology/Oncology; Richard A. Perritt, MD Professorship in Cancer and Blood Disorders

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Interim Director, Cancer Biology & Epigenomics Program, Stanley Manne Children's Research Institute

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Differentiation and development, molecular oncogenesis, sarcoma treatment, solid tumor therapy

Specialties, Programs & Conditions

Specialties:

Pediatric Hematology & Oncology >

Education & Training

Education: University of Michigan, 1983

Postgraduate Training: Children's Hospital of Philadelphia, 1989, 1986, 1984

Board Certifications: Pediatric Hematology-Oncology, General Pediatrics

Research

Research Interests: Cancer biology; developmental biology; oncology; pediatrics; signal transduction

Publications

Most recent publications

Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups Pediatr Blood Cancer e27096
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group Pediatr Blood Cancer 64 (9):
Sonic hedgehog regulation of Foxf2 promotes cranial neural crest mesenchyme proliferation and is disrupted in cleft lip morphogenesis Development 144 (11): 2082-2091
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group Cancer 123 (12): 2368-2375
Final Report of a Prospective Clinical Trial of Cardiac Sparing Whole-Lung Intensity Modulated Radiation Therapy in Patients With Metastatic Pediatric Tumors Int J Radiat Oncol Biol Phys 96 (2S): S118-S119
Is 45 Gy a Sufficient Radiation Therapy Dose for Unresected Orbital Embryonal Rhabdomyosarcoma? A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group Int J Radiat Oncol Biol Phys 96 (2S): E548
Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer Pediatr Blood Cancer 63 (11): 2011-8
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group Pediatr Blood Cancer 63 (4): 634-9
Resection of Intrapericardial Rhabdomyosarcoma in a Child World J Pediatr Congenit Heart Surg 7 (1): 108-11
Treatment of neuroblastoma in congenital central hypoventilation syndrome with a PHOX2B polyalanine repeat expansion mutation: New twist on a neurocristopathy syndrome Pediatr Blood Cancer 62 (11): 2007-10

David O. Walterhouse, MD

David O. Walterhouse, MD

Section Head, Oncology; Attending physician, Hematology/Oncology; Richard A. Perritt, MD Professorship in Cancer and Blood Disorders

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Interim Director, Cancer Biology & Epigenomics Program, Stanley Manne Children's Research Institute

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Specialties, Programs & Conditions

Education & Training

Research

Publications

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

Locations